Thank you, Ted. As I typically do during this portion of the call, I'll cover the following topics: an overview of our 2023 first quarter results along with an overview of related key operating statistics, an overview of our cash flow activities in the quarter, and I'll then conclude with a discussion on our financial outlook for the second quarter of 2023. For purpose of this call, I will comment separately regarding the revenues of our global S&BT segment, our Oracle Solutions Segment, our SAP Solutions Segment and the total company. Our global S&BT segment includes the results of our North America and international IP as a Service offerings, our research advisory programs, our benchmarking services, our business transformation and our onstream offerings. Our Oracle Solutions and our SAP Solutions segments include the results of our Oracle and SAP offerings respectively. Please note that we will be referencing both total revenues and revenue before reimbursements in our discussions. Reimbursable expenses are primarily project travel-related expenses passed through to our clients and have no associated effect from our profitability. During our call today, we will also reference certain non-GAAP financial measures, which we believe provide useful information to investors. We have included reconciliations of GAAP to non-GAAP financial measures in our press release filed earlier today and will post any additional information based on the discussions from this call to the Investor Relations page of the Company's website. For the first quarter of 2023, our revenue was $71.2 million. Our revenues before reimbursements were $69.8 million, which was in line with our quarterly guidance. As we discussed last quarter, during the first half of fiscal 2022, we experienced stronger-than-expected post COVID pent-up demand that drove strong results in the prior year. The Q1 2023 reimbursable expense ratio on revenues before reimbursements was 2% as compared to 1.9% in the prior quarter and 0.7% when compared to the same period in the prior year. Post COVID, we have experienced increased client-related travel. However, given the market's transition to a remote delivery model, we do not expect these project-related travel expenses to return to pre-COVID levels. Total revenues from our global S&BT segment was $42.3 million for the first quarter of 2023. Revenues before reimbursements for our global S&BT segment was $41.7 million for the first quarter of 2023, a decrease of 1.7% when compared to the same period in the prior year, but down 1% on a local currency basis utilizing the same foreign currency rates in Q1 of the prior year. Total revenues from our Oracle Solutions Segment were $17.2 million for the first quarter of 2023. Revenues before reimbursements for Oracle Solutions Segment were $16.7 million for the first quarter, a decrease of 22% when compared to the same period in the prior year as we expected and as we guided per our last quarter. Oracle Solutions was coming off of solid 2022 results and was rebuilding its pipeline in light of unfavorable macroeconomic conditions as we entered the first quarter. However, given a number of significant engagements, which closed towards the end of the first quarter, we now expect Oracle will be up strongly on a sequential basis as we move into Q2. Total revenues from our SAP Solutions Segment were $11.7 million for the first quarter of 2023. Revenues before reimbursements for our SAP Solutions Segment were $11.5 million for the first quarter, an increase of 1.3% when compared to the same period in the prior year. Approximately 23% of our total company revenues for reimbursements consists of recurring multiyear and subscription-based revenues, which include our research advisory, IP as a service, multiyear benchmarks and application managed services contracts. Total company adjusted cost of sales, which exclude reimbursable expenses and noncash stock-based compensation expense totaled $41.6 million or 59.6% of revenues before reimbursements in the first quarter of 2023 as compared to $45.7 million or 60.8% of revenue before reimbursements in the prior year. Total company consultant headcount was 1,101 at the end of the first quarter as compared to a total company consultant headcount of 1,120 in the previous quarter and 1,141 at the end of the first quarter of 2022. Total company adjusted gross margin on revenues before reimbursements, which excludes reimbursable expenses and noncash stock-based compensation expense was 40.4% in the first quarter of 2023 as compared to 39.2% in the prior year period. The 120 basis point gross margin improvement was primarily driven by the relative mix of higher-margin global S&BT segment revenues. Adjusted SG&A, which excludes noncash stock-based compensation expense and intangible asset amortization was $14.5 million or 20.8% of revenues before reimbursements in the first quarter of 2023. This is compared to $13.3 million or 17.7% revenues before reimbursements in the prior year. The year-over-year absolute dollar increase is primarily due to incremental investments we are making in program development and dedicated sales resources for our benchmarking, executive advisory, market intelligence and our IP service offerings. These investments approximated $0.03 in the first quarter of 2023. Adjusted EBITDA, which excludes noncash stock-based compensation expense and intangible asset amortization was $14.5 million or 20.8% of revenues before reimbursements in the first quarter as compared to $17 million or 22.6% of revenues before reimbursements in the prior year. GAAP net income for the first quarter of 2023 totaled $8.2 million or diluted earnings per share of $0.30 as compared to GAAP net income of $10.5 million or diluted earnings per share of $0.33 in the first quarter of previous year. Adjusted net income, which excludes noncash stock-based compensation expense and intangible asset amortization for the first quarter of 2023 totaled $10 million or adjusted diluted net income per common share of $0.37, which is in line with our earnings guidance range. This compares to adjusted net income of $12.6 million or invested diluted net income per share of $0.39 in the first quarter of the prior year. In Q2 of 2022, we moved to an actual GAAP effective tax rate for adjusted net income reporting purposes. For those of you reconciled to the prior year reported results in Q1, we reported adjusted diluted income per common share of $0.38 when utilizing a non-GAAP effective tax rate of 25%. The Company's cash balances were $16.9 million at the end of the first quarter of 2023 as compared to $30.3 million at the end of the previous quarter. Net cash used in operating activities in the quarter was $3.1 million, primarily driven by decreases in accrued expenses due to the payment of 2022 performance bonuses and increases in accounts receivable, partially offset by net income adjusted for noncash activity. Our DSO or day sales outstanding at the end of the quarter was 66 days as compared to 63 days at the end of the previous quarter. During the quarter, we repurchased 199,000 shares of the Company's stock for an average of $21.23 per share at a total cost of approximately $4.2 million, driven by purchases from employees to satisfy income tax holding triggered by the vesting of restricted shares as well as for share repurchases. Our remaining stock repurchase authorization at the end of the quarter was $14.0 million. During the quarter, the Company paid down $2 million on our credit facility. The balance of the Company's total debt attending at the end of the first quarter is approximately $58 million. At its most recent meeting, subsequent to quarter end, the Company's Board of Directors declared the second quarterly dividend of $0.11 per share for shareholders of record on June 23, 2023, to be paid on July 7, 2023. Now moving to the second quarter of 2023 and our guidance. The Company currently estimates total revenue before reimbursements for the second quarter of 2023 to be in the range of $72.5 million to $74 million. We expect global S&BT segment revenue before reimbursements to be slightly down when compared to the prior year as we expect slowing economic growth to result in extended client decision-making and business transformation engagements. We expect Oracle Solutions Segment revenue before reimbursements to be up strongly on a sequential basis and to be only slightly down when compared to the prior year. We expect SAP Solutions Segment revenue before reimbursements to be up on a year-over-year basis. We estimate adjusted diluted net income per common share in the second quarter of 2023 to be in the range of $0.36 to $0.39, which assumes a GAAP effective tax rate on adjusted earnings of 27%. As Ted mentioned last quarter, the second quarter will reflect the continued incremental investments we are making in program development and dedicated sales resources for our benchmarking executive advisory, market intelligence and our IP as a service offerings. These incremental costs are expected to impact our diluted net income per common share for approximately $0.04 when compared to the prior year. We expect adjusted gross margin on revenues before reimbursements to be approximately 42% to 43%. We expect adjusted SG&A and interest expense for the second quarter to be approximately $16.7 million. We expect second quarter adjusted EBITDA on revenues before reimbursements to be in the range of approximately 21% to 23%. Lastly, we expect cash flow from operations to be up on a sequential basis. At this point, I would like to turn it back over to Ted to review our market outlook and strategic priorities for the coming months.